About
Neosoma develops a cloud-based FDA-cleared software platform that automates volumetric measurement, lesion mapping, and tracking for neuro-oncology patients to support multidisciplinary brain cancer care.
Explore Neosoma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.